Involvement of CD40–CD40 Ligand in Uncomplicated and Refractory Celiac Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Gastroenterology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2010.450PMID 21139574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of IL-17A–Producing Cells in Celiac Disease Mucosa

  2010cited by this paper
• Serum Levels of Soluble CD40 Ligand at Flare and at Remission in Patients with Systemic Lupus Erythematosus

  2009cited by this paper
• The multi-functionality of CD40L and its receptor CD40 in atherosclerosis

  2009cited by this paper
• Coeliac disease.

  2009cited by this paper
• Dendritic cells in intestinal homeostasis and disease.

  2009cited by this paper
• Outside inside signalling in CD40-mediated B cell activation.

  2007cited by this paper
• Increased serum soluble CD40 levels in patients with systemic sclerosis.

  2007cited by this paper
• Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.

  2007cited by this paper
• A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.

  2006cited by this paper
• Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.

  2006cited by this paper
• Coeliac disease

  2005cited by this paper
• Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.

  2005cited by this paper
• Immunity, Inflammation, and Allergy in the Gut

  2005cited by this paper
• Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa

  2004cited by this paper
• The Role of CD40–CD154 Interactions in Autoimmunity and the Benefit of Disrupting this Pathway

  2004cited by this paper
• The CD40/CD40L costimulatory pathway in inflammatory bowel disease

  2004cited by this paper
• Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal Digestion1

  2004cited by this paper
• Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease

  2004cited by this paper
• Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.

  2003cited by this paper
• Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

  2003cited by this paper
• Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases

  2003cited by this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cited by this paper
• Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.

  2003cited by this paper
• CD40/CD154 ligation is required for the development of acute ileitis following oral infection with an intracellular pathogen in mice.

  2002cited by this paper
• CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis.

  2002cited by this paper
• Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease

  2001cited by this paper
• The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review

  2001cited by this paper
• Reply to Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

  2000cited by this paper
• A novel transcription factor, T-bet, directs Th1 lineage commitment.

  2000cited by this paper
• Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration.

  2000cited by this paper
• Prevention of Experimental Colitis in SCID Mice Reconstituted with CD45RBhigh CD4+ T Cells by Blocking the CD40-CD154 Interactions1

  2000cited by this paper
• CD40‐CD40 ligand

  2000cited by this paper
• Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.

  1999cited by this paper
• Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease.

  1998cited by this paper
• Blockage of T-cell costimulation inhibits T-cell action in celiac disease.

  1998cited by this paper
• CD40 and CD154 in cell-mediated immunity.

  1998cited by this paper
• A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction

  1997cited by this paper
• Functions of CD40 on B cells, dendritic cells and other cells.

  1997cited by this paper
• Functional CD40 antigen on B cells, dendritic cells and fibroblasts.

  1995cited by this paper
• The CD40 antigen and its ligand.

  1994cited by this paper

• Natural Killer Cells Reprogram Myeloid-Derived Suppressor Cells to Induce TNF-α Release via NKG2D–Ligand Interaction after Cryo-Thermal Therapy

  2024cites this paper
• Enteropathy Markers in Early Life Were Associated with Adipokine, Apolipoprotein, and Cytokine Profiles Consistent with an Adverse Cardiometabolic Disease Risk Profile Later in Childhood in a Peruvian Birth Cohort

  2022cites this paper
• Human intestinal dendritic cell and macrophage subsets in coeliac disease.

  2021cites this paper
• Early-life enteric infection and enteropathy markers are associated with changes in adipokine, apolipoprotein and cytokine profiles later in childhood consistent with those of an adverse cardiometabolic disease risk profile in a Peruvian birth cohort.

  2021cites this paper
• Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins.

  2019cites this paper
• The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review

  2019cites this paper
• New coeliac disease treatments and their complications.

  2018cites this paper
• New coeliac disease treatments and their complications

  2018cites this paper
• Nuevas terapias en la enfermedad celiaca y sus complicaciones

  2018cites this paper
• Immune receptors CD40 and CD86 in oral keratinocytes and implications for oral lichen planus.

  2017cites this paper
• Immune receptors CD 40 and CD 86 in oral keratinocytes and implications for oral lichen planus

  2017cites this paper
• Gastroenterología y Hepatología

  2016cites this paper
• Current and novel therapeutic strategies in celiac disease

  2016cites this paper
• Polyamine supplementation in infant formula: Influence on lymphocyte populations and immune system-related gene expression in a Balb/cOlaHsd mouse model

  2014cites this paper
• IL-17 Producing T Cells in Celiac Disease: Angels or Devils?

  2013cites this paper
• Intestinal T-cell Responses in Celiac Disease – Impact of Celiac Disease Associated Bacteria

  2013cites this paper
• Nondietary therapies for celiac disease.

  2012cites this paper